Essa Pharma
Investors/Media

With a focus on the development of small molecule drugs for the treatment of cancer, the goal at ESSA is to develop a pipeline of oncology therapeutics. We will continue to research innovative ideas with the goal of providing a promising future for the patients and community we serve.

With a focus on the development of small molecule drugs for the treatment of cancer, the goal at ESSA is to develop a pipeline of oncology therapeutics. We will continue to research innovative ideas with the goal of providing a promising future for the patients and community we serve.

Latest News
Nov 18, 2021
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2021

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a...

Nov 8, 2021
ESSA Pharma to Participate in Three Upcoming Investor Conferences

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that...

Oct 28, 2021
ESSA Pharma Presents at 28th Annual Prostate Cancer Foundation Scientific Retreat

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the...

View All News

View All

Stock Performance

Last Price

Change

Volume

NASDAQEPIX
Learn More

Investor & Media Contacts

INVESTORS
Xuan Yang
Senior Vice President
Solebury Trout
xyang@soleburytrout.com

MEDIA
Zara Lockshin
Senior Associate
Solebury Trout
zlockshin@soleburytrout.com